Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,831 | $1,668 | $3,822 | $3,623 |
| Short-Term Investments | $3,582 | $6,122 | $7,731 | $10,434 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $603 | $689 | $944 | $869 |
| Total Curr. Assets | $6,015 | $8,479 | $12,497 | $14,926 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $408 | $433 | $458 | $483 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $300 |
| Total NC Assets | $408 | $433 | $458 | $783 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,424 | $8,913 | $12,955 | $15,709 |
| Liabilities | – | – | – | – |
| Payables | $1,861 | $874 | $644 | $906 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $54 | $62 | $63 | $78 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,850 | $3,402 | $4,148 | $3,198 |
| Total Curr. Liab. | $5,765 | $4,337 | $4,856 | $4,181 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,874 | $2,024 | $2,174 | $2,324 |
| Total NC Liab. | $1,874 | $2,024 | $2,174 | $2,324 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,638 | $6,361 | $7,029 | $6,505 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$66,622 | -$62,674 | -$58,978 | -$55,166 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $65,407 | $65,225 | $64,904 | $64,370 |
| Total Equity | -$1,215 | $2,551 | $5,926 | $9,205 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,424 | $8,913 | $12,955 | $15,709 |
| Net Debt | -$1,831 | -$1,668 | -$3,822 | -$3,623 |